Page 7 - Robert Berman News Today

REKR earnings call for the period ending June 30, 2021.

Published: May 13, 2021   -- Bob Linke appointed Chief Executive Officer   NEW HAVEN, Conn.--(BUSINESS WIRE)-- Osmol Therapeutics today announced that it has initiated Investigational New Drug (IND) enabling studies to develop a therapy to prevent chemotherapy-induced peripheral neuropathy (CIPN). A phase 1 clinical study is projected to begin in 2022. There are currently no Food and Drug Administration (FDA) approved therapies for the prevention or treatment of CIPN, a debilitating condi...

Rekor Systems, Inc. (REKR) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Rekor Systems, Inc. (NASDAQ: REKR) Q1 2021 Earnings Call Good afternoon ladies and gentlemen, and welcome to todays Rekor Systems, Inc. conference call. My name is Darryl and Ill be your coordinator for today. [Operator Instructions] Before we get started, Id like to read you the companys abbreviated safe harbor statement. Id like to...

Photo: marcoventuriniautieri/Getty Images In March, the president of Rekor Systems Inc., Robert Berman, told investors that 2020 was a “transformative year.” The surveillance tech company’s platform, Rekor One, which converts regular cameras into automated license plate readers (ALPR), had proven alluring to cash-strapped state governments during the Covid-19 pandemic. Oklahoma, which has seen its tax revenue plummet alongside falling oil prices, announced a statewide rollout of Rekor One...

Hancock Jaffe Laboratories, Inc.: First U.S. Patent Issues on Hancock Jaffe VenoValve / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that the United States Patent and Trademark Office (USPTO) has issued the first patent covering the companys VenoValve. The patent is entitled Implantable Vein Frame and is U.S. patent number 10,959,841. The company recently announced that only twenty-eight (28) days aft...

Rekor Systems, Inc. (REKR) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Rekor Systems, Inc. (NASDAQ: REKR) Q4 2020 Earnings Call Operator Good afternoon, ladies and gentlemen, and welcome to todays Rekor Systems, Inc. conference Call. My name is Joe, and I will be your coordinator for today. [Operator Instructions] Before we get started, Id like to read you the companys abbreviated safe harbor statement....

Biden CANCELS Dr. Seuss: President bucks predecessors and omits author from his Read Across America Day proclamation after Virginia school systems drops iconic childrens books because of racial undertones President Joe Biden did not mention Dr. Seuss during his proclamation for Read Across America day bucking a more than 20 year trend  Presidents Clinton, Obama and Trump have all mentioned Seuss in conjunction with the day designed to encourage school children to read more  Bidens omission co...

Neon Nettle - Biden Cancels Dr Seuss: Scrubs Mention of Books from Read Across America Day - Democrat bucks decades-old tradition of encouraging children to read Dr. Seuss

Lisa M. Berman Berman Arts Agency has one of the most premier and satisfied client lists LOS ANGELES, CA, UNITED STATES, February 26, 2021 /EINPresswire.com/ -- Globally, Covid-19 has affected us all, many in personal ways, yet the creative industry has been one the hardest hit. As I listened intently to the 2021 Creative Economy Report presented by Otis College of Art & Design, I couldn’t help being blind-sided by the tremendous financial impact the pandemic had on Arts related industries in...

Hancock Jaffe Laboratories, Inc.: First U.S. Patent Allowed on Hancock Jaffe VenoValve IRVINE, CA / ACCESSWIRE / February 24, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent covering the companys VenoValve. The patent, which focuses on novel aspects of the VenoValve frame, will be the ...